Biopharmaceutical company Theravance Biopharma has enrolled its first patient in a Phase 3 registrational study of telavancin’s efficacy in fighting Staphylococcus aureus bacteremia, officially ...
Sept 27 (Reuters) - An antibiotic already in use in Europe to treat pneumonia controlled deadly bloodstream infections with Staphylococcus aureus bacteria just as effectively as the most powerful ...
Oct. 23, 2002 (Boston) — Doctors need to be alert for an antibiotic-resistant form of a common staph infection that is quickly spreading in some communities, researchers reported at American Academy ...
WASHINGTON -- Investigational ceftobiprole was just as effective as daptomycin for bacterial bloodstream infections caused by Staphylococcus aureus bacteremia, the phase III ERADICATE trial ...
Researchers have uncovered an elegant system that contributes to antibiotic tolerance in the 'superbug' Staphylococcus aureus, identifying and characterizing a mechanism for drug tolerance and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results